Sportschosun reporter Jang Jong-ho] A path has opened for the early identification of people at high risk of Alzheimer's ...

Caris Life Sciences® , a leading patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the commercial launch of Caris Detecttm, a groundbreaking ...

Juniper Genomics, a health-tech company pioneering a new standard of care in IVF, today announced the launch of Juniper Insight. Juniper Insight is a fertility genetic test built to fill a ...

Zoraptera, also known as angel insects or ground lice, are tiny termite-like insects generally found underneath bark or in ...

Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced the dual listing of its common stock on NYSE Texas ...

A quantum-inspired AI approach can analyze millions of molecular features from small datasets, improving predictions, ...

Over the past two decades, high‑throughput sequencing has dramatically expanded our understanding of the gut microbiome's composition.

A new study constructs the first 3D single-cell brain atlas of the lamprey, uncovering the 450-million-year-old molecular ...

Dr. Deng gives a presentation on his research at the Anne Heidenthal Award presentation hosted at the International Conference on Systems Biology of Human Disease.

Is CAI a good stock to buy? We came across a bullish thesis on Caris Life Sciences, Inc. on InfoArb Sheets’s Substack. In this article, we will summarize the bulls’ thesis on CAI. Caris Life Sciences, ...

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), today announced that the company’s Trekker Single-Cell Spatial Mapping Kit, a platform-agnostic, instrument-free ...

Aging, at its most fundamental level, is a molecular process. Chemical marks on the genome shift and lose fidelity over time, ...